CORRECTION of abnormally low concentration of plasma components is usually attempted by replacement therapy. However, evidence from studies of purpura fulminans in man 1,2 and from studies of the ...
The "INSIGHT" trial: An explorative, open-labeled phase I study to evaluate the feasibility and safety of intra-tumoral, intra-peritoneal, and subcutaneous injections with IMP321 (LAG-3Ig fusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results